210 related articles for article (PubMed ID: 18398806)
1. The importance of treating cardiometabolic risk factors in patients with type 2 diabetes.
Barnett AH
Diab Vasc Dis Res; 2008 Mar; 5(1):9-14. PubMed ID: 18398806
[TBL] [Abstract][Full Text] [Related]
2. The progression of cardiovascular risk to cardiovascular disease.
Rosin BL
Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
[TBL] [Abstract][Full Text] [Related]
3. Abdominal adiposity and cardiometabolic risk: do we have all the answers?
Haffner SM
Am J Med; 2007 Sep; 120(9 Suppl 1):S10-6; discussion S16-7. PubMed ID: 17720354
[TBL] [Abstract][Full Text] [Related]
4. Adipokines--targeting a root cause of cardiometabolic risk.
Bakhai A
QJM; 2008 Oct; 101(10):767-76. PubMed ID: 18550581
[TBL] [Abstract][Full Text] [Related]
5. New insights into understanding cardiometabolic risk. Introduction.
Fonarow GC; Watson KE
Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
[No Abstract] [Full Text] [Related]
6. The importance of treating multiple cardiometabolic risk factors in patients with Type 2 diabetes.
Mikhailidis DP; Press M
Expert Opin Pharmacother; 2007 Dec; 8(17):3009-20. PubMed ID: 18001259
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of early cardiometabolic risk factors in children and adolescents with Turner syndrome.
O'Gorman CS; Syme C; Lang J; Bradley TJ; Wells GD; Hamilton JK
Clin Endocrinol (Oxf); 2013 Jun; 78(6):907-13. PubMed ID: 23106295
[TBL] [Abstract][Full Text] [Related]
8. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
[TBL] [Abstract][Full Text] [Related]
9. The endocannabinoid system and cardiometabolic risk.
Szmitko PE; Verma S
Atherosclerosis; 2008 Aug; 199(2):248-56. PubMed ID: 18440538
[TBL] [Abstract][Full Text] [Related]
10. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
Lee M; Aronne LJ
Am J Cardiol; 2007 Feb; 99(4A):68B-79B. PubMed ID: 17307059
[TBL] [Abstract][Full Text] [Related]
11. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
Kravchun P; Kadykova O; Gabisoniia T
Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
[TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
Goralski KB; Sinal CJ
Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251
[TBL] [Abstract][Full Text] [Related]
13. Challenges and strategies in managing cardiometabolic risk.
Repas TB
J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S4-11. PubMed ID: 17784529
[TBL] [Abstract][Full Text] [Related]
14. Overweight and obesity: the pathogenesis of cardiometabolic risk.
Bray GA; Clearfield MB; Fintel DJ; Nelinson DS
Clin Cornerstone; 2009; 9(4):30-40; discussion 41-2. PubMed ID: 19789062
[TBL] [Abstract][Full Text] [Related]
15. [From the metabolic syndrome to the concept of global cardiometabolic risk].
Nádas J; Jermendy G
Orv Hetil; 2009 May; 150(18):821-9. PubMed ID: 19383573
[TBL] [Abstract][Full Text] [Related]
16. Advances in adipokines.
Sahin-Efe A; Katsikeris F; Mantzoros CS
Metabolism; 2012 Dec; 61(12):1659-65. PubMed ID: 23021039
[No Abstract] [Full Text] [Related]
17. The metabolic syndrome: metabolic changes with vascular consequences.
Wassink AM; Olijhoek JK; Visseren FL
Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
[TBL] [Abstract][Full Text] [Related]
18. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue.
Lafontan M; Girard J
Diabetes Metab; 2008 Sep; 34(4 Pt 1):317-27. PubMed ID: 18550411
[TBL] [Abstract][Full Text] [Related]
19. Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome.
Carmina E
Front Horm Res; 2013; 40():40-50. PubMed ID: 24002404
[TBL] [Abstract][Full Text] [Related]
20. Metabolic complications of obesity: inflated or inflamed?
Chandalia M; Abate N
J Diabetes Complications; 2007; 21(2):128-36. PubMed ID: 17331862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
